Prognostic Value of N-Terminal Pro-Brain Natriuretic Peptide in Outpatients With Hypertrophic Cardiomyopathy

Dec 5, 2016 by in CARDIOLOGY Comments Off on Prognostic Value of N-Terminal Pro-Brain Natriuretic Peptide in Outpatients With Hypertrophic Cardiomyopathy

In hypertrophic cardiomyopathy, the plasma levels of N-terminal pro-brain natriuretic peptide (NT-proBNP) correlate with functional capacity. However, their prognostic relevance remains unresolved. We followed up 183 stable outpatients with hypertrophic…

read more

Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy According to Revised 2010 Task Force Criteria With Inclusion of Non-Desmosomal Phospholamban Mutation Carriers

Dec 5, 2016 by in CARDIOLOGY Comments Off on Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy According to Revised 2010 Task Force Criteria With Inclusion of Non-Desmosomal Phospholamban Mutation Carriers

Arrhythmogenic right ventricular dysplasia/cardiomyopathy (ARVD/C) is frequently associated with desmosomal mutations. However, nondesmosomal mutations may be involved. The aim of this study was to assess the contribution of a phospholamban…

read more

Comparison of Clinical Presentation, Left Ventricular Morphology, Hemodynamics, and Exercise Tolerance in Obese Versus Nonobese Patients With Hypertrophic Cardiomyopathy

Dec 5, 2016 by in CARDIOLOGY Comments Off on Comparison of Clinical Presentation, Left Ventricular Morphology, Hemodynamics, and Exercise Tolerance in Obese Versus Nonobese Patients With Hypertrophic Cardiomyopathy

Obesity is independently associated with left ventricular (LV) hypertrophy and thus may be an important modifier of the hypertrophic cardiomyopathy (HC) phenotype. We examined if obesity modifies the clinical presentation,…

read more

Impact of a Multidisciplinary Management Strategy on the Outcome of Patients With Native Valve Infective Endocarditis

Dec 5, 2016 by in CARDIOLOGY Comments Off on Impact of a Multidisciplinary Management Strategy on the Outcome of Patients With Native Valve Infective Endocarditis

Strategies to improve management of patients with native valve endocarditis (NVE) are needed because of persistently high morbidity and mortality. We sought to assess the impact of an operative protocol…

read more

A Simple Validated Clinical Tool to Predict the Absence of Coronary Artery Disease in Patients With Systolic Heart Failure of Unclear Etiology

Dec 5, 2016 by in CARDIOLOGY Comments Off on A Simple Validated Clinical Tool to Predict the Absence of Coronary Artery Disease in Patients With Systolic Heart Failure of Unclear Etiology

Coronary artery disease (CAD) is a major cause of systolic heart failure (HF). Identifying CAD as a cause of systolic HF has prognostic and treatment implications. Whether all patients with…

read more

Prevalence, Clinical Characteristics, and Outcomes Associated With Eccentric Versus Concentric Left Ventricular Hypertrophy in Heart Failure With Preserved Ejection Fraction

Dec 5, 2016 by in CARDIOLOGY Comments Off on Prevalence, Clinical Characteristics, and Outcomes Associated With Eccentric Versus Concentric Left Ventricular Hypertrophy in Heart Failure With Preserved Ejection Fraction

Although concentric remodeling (CR) and concentric hypertrophy (CH) are common forms of left ventricular (LV) remodeling in heart failure with preserved ejection fraction (HFpEF), eccentric hypertrophy (EH) can also occur…

read more

Antitachycardia Pacing for Very Fast Ventricular Tachycardia and Low-Energy Shock for Ventricular Arrhythmias in Patients With Implantable Defibrillators

Dec 5, 2016 by in CARDIOLOGY Comments Off on Antitachycardia Pacing for Very Fast Ventricular Tachycardia and Low-Energy Shock for Ventricular Arrhythmias in Patients With Implantable Defibrillators

Implantable cardioverter-defibrillator therapy in the form of high-energy shock (HES) is associated with adverse effects. This study evaluated an alternative therapy to HES, including antitachycardia pacing (ATP) for very fast…

read more
Get Clinical Tree app for offline access